• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • 2.0 LPBI Brochure
  • Coronavirus, SARS-CoV-2 Portal
  • Knowledge PORTALS System (KPS)
  • Journal PharmaceuticalIntelligence.com
  • 2020-21 VISTA 1.0 LPBI
  • LPBI Group’s History
  • 2020-21 VISION – 2.0 LPBI
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • LPBI Group News
  • CALENDAR
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2020 Summer Internship Portal
  • 2021 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

LPBI Group’s History

LPBI Group’s History

For 2019 – 2020 click on 2019 VISTA

https://pharmaceuticalintelligence.com/2019-vista/

 

 

Year End 2016 Statement on Yearly Progress by LPBI Group

Curator: Aviva Lev-Ari, PhD, RN

LPBI Group has Three Enterprise Types and Five Subsidiaries as described, below.

pharma_bi-background0238 copy

 Image Source: Google Images

We are in Knowledge-based Informational Services

Line-of-Business #1:

Open Access OnLine Scientific Journal  

  • 1,121,301 e-Readers, Site Statistics on 12/26/2016 

June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

  • 5,005 Scientific Articles, Site Statistics on 12/26/2016 

We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!

Curator and Open Access Journal Editor-in-Chief: Aviva Lev-Ari, PhD, RN

 

  • Top Authors for All Days ending 2016-12-01: GROWTH Trends @Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Curator: Aviva Lev-Ari, PhD, RN

 

  • 7,267 Comments by Scientists, Site Statistics on 12/26/2016 
  • 2,183 Subscribers, Site Statistics on 12/26/2016

 

Line-of-Business #2:

BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 7 e-Books in 2017

  • New e-Book TITLES forthcoming on Amazon.com in 2016 from LPBI Group’s BioMed e-Series –Forthcoming COVER PAGES

Editor-in-Chief, Aviva Lev-Ari, PhD, RN

 

Line-of-Business #3:

Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events

  • Super RECORD of REAL TIME Coverage of Biotech and Medicine Conferences by LPBI Group in 2016

Curator: Aviva Lev-Ari, PhD, RN

Line-of-Business #4: No Progress in 2016

Audio-Podcast Series in Medicine, 5 tracks

&

  • Subsidiary 4: Intellectual Property Asset Management

Line-of-Business #5: New Patents issued to Bill Zurn

Representation of US Patent Holders for Commercialization, Licensing and Partnerships

We are in Research Biotech Businesses

 

  • Subsidiary 3: R&D in 3D BioPrinting

Line-of-Business #6:

Tissue Engineering, Gene Therapy: Stem Cells & Gene Editing, Medical Devices: Product Concepts

  • 3D Medical BioPrinting Technology Reporting by Irina Robu, PhD – a forthcoming Article in “Medical 3D BioPrinting – The Revolution in Medicine, Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices”

Curator: Aviva Lev-Ari, PhD, RN

 

  • Volume Four: Medical 3D BioPrinting – The Revolution in Medicine

Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices

Editors: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

&

  • Subsidiary 5: Pharmaceutical R&D: Drug Discovery and Drug-Devices Development

Line-of-Business #7:

  • Drug Discovery with 3D BioPrinting

Team developing new mechanism of action for Therapeutics and Diagnostics for Early Detection of Pancreatic Cancer

 

Line-of-Business #8:

  • Drug Delivery System – One solution for many agents for many indications

Team developing solutions with Nanoparticles and with Exosomes 

We are in Business Financial Transactions (No Securities Traded)

 

  • Subsidiary 2: Funding Early Stage Businesses, IP Licensing and Business Partnerships:

Line-of-Business #9:

Early Stage Venture Funding

MEDICAL DEVICES

Pharmaceutical Informational PLATFORMS

INVENTIONS IN BIOLOGICS

Representation of 13 ventures for the purpose of prospecting for funding. Seeking business partner to developing FUNDING of the following Ventures, if interested to further explore jointly, please e-mail me:

avivalev-ari@alum.berkeley.edu

 

  • LPBI Group’s Portfolio of Clients include the following:

 

  1. Woodland Pharmaceutical

https://gust.com/companies/woodland_pharmaceuticals

 

  1. BioTerm Pharmaceuticals

http://www.bio-term.com/

 

  1. Akshaya Bio Inc. – Portfolio of 28 Patents in vaccine – viral infection

http://www.akshayabio.com/

 

  1. ValveCure.com

http://www.valvecure.com/Home.html

 

  1. Alpha Sensors, Inc.

http://alphaszenszor.com/

 

  1. AlphaIP, Inc.

http://www.alphaip.net/

 

  1. SBH Sciences, Inc

http://www.sbhsciences.com/

 

  1. Telerescue

http://www.telerescue.co.il/

 

  1. New Medicine, Inc.

http://www.newmedinc.com/

 

  1. LPBI Group – Aviva Lev-Ari, PhD, RN – Founder

https://pharmaceuticalintelligence.com/gama-delta-epsilon-gde-is-a-global-holding-company-absorbing-lpbi/

 

10a. DrugDiscovery @LPBI Group – Aviva Lev-Ari, PhD, RN – Co–Founder and Raphael Nir, PhD – Co–Founder

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

 

  1. Portfolio of Patents of S.Y. in Anti-Inflammatory, A Macro Molecule of a Multifunctional NSAID – Portfolio of 13 US Patents

Multi-Functional Anti-Inflammatory Drugs (MFAIDs): Small Molecule Invention of Dr. Saul Yedgar, HUJI and Yissum

 

  1. Portfolio of Patents under management of Y. M.

 

  1. Vyriad – Oncolytic Virotherapy for the Treatment of Cancer
    Vyriad – http://www.vyriad.com/

 

In Preparation: VB Profile

http://pages.vbprofiles.com/TheMostPopularLists

 

 

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Print
  • Email

Like this:

Like Loading...

This page has the following sub pages.

  • LPBI Group’s Vision
  • Subsidiary 1: Leaders in Pharmaceutical Business Intelligence (LPBI) – Scientific Digital MEDIA
  • Subsidiary 2: Deals, Funding & Partnerships – DFP
  • Subsidiary 3: Medical 3D BioPrinting – M3DP
  • Subsidiary 4: US Patents & International Patents – Commercialization, Licensing & Sales (USPat)
  • Subsidiary 5: Joint Ventures for IP Development – JVIP
  • EXPLORATION INTO FIRST ROUND OF INVESTMENT FOR LPBI Group
  • 2016 Strategic Plan for LPBI Group

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,053 other followers

  • Recent Posts

    • Allon Klein, Harvard Medical School, and Aviv Regev, Genentech, Recipients of National Academy of Sciences James Prize in Science and Technology Integration 2021 Award  January 19, 2021
    • World Leaders to meet during Davos Agenda in a crucial year to rebuild trust January 18, 2021
    • Joe Biden Announced Science Team Nominations for the New Administration January 17, 2021
    • Potential Interest in LPBI Group’s BioMed e-Series January 17, 2021
    • Dysregulation of ncRNAs in association with Neurodegenerative Disorders January 11, 2021
    • Early Details of Brain Damage in COVID-19 Patients January 9, 2021
    • Cancer treatment using CRISPR-based Genome Editing System January 9, 2021
    • e-Voices Podcasting by LPBI: Celebrating Podcast #3 in an Audio Library on leading Scientists and Key Opinion Leaders in Biological Sciences January 9, 2021
    • Retrospective Study of National Danish Registry Sheds Light on Cardiotoxic Risks of Immune Checkpoint Inhibitors January 8, 2021
    • Leaders in Pharmaceutical Business Intelligence & youngStartup Ventures: Venture Summit Virtual Connect West, March 16th -18th 2021 featuring a dedicated Lifesciences / Healthcare Track   January 6, 2021
  • Archives

  • Categories

  • Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.com
    • 2012pharmaceutical
    • Amandeep Kaur
    • Aashir Awan, Phd
    • Adina Hazan
    • Alan F. Kaul, PharmD., MS, MBA, FCCP
    • alexcrystal6
    • anamikasarkar
    • apreconasia
    • aviralvatsa
    • David Orchard-Webb, PhD
    • danutdaagmailcom
    • Demet Sag, Ph.D., CRA, GCP
    • Daniel Menzin
    • Dror Nir
    • dsmolyar
    • evelinacohn
    • Gail S Thornton
    • Irina Robu
    • jayzmit48
    • jdpmd
    • jshertok
    • kellyperlman
    • Ed Kislauskis
    • larryhbern
    • Madison Davis
    • marzankhan
    • megbaker58
    • ofermar2020
    • pkandala
    • Rosalind Codrington, PhD
    • ritusaxena
    • Rick Mandahl
    • sjwilliamspa
    • stuartlpbi
    • Dr. Sudipta Saha
    • tildabarliya
    • zraviv06
    • zs22

Blog at WordPress.com.

WPThemes.


Cancel
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: